Your presentation appearance sends a message, and you cannot expect an audience to disregard the message your...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
MERCK & CO.
Merck & Co. Inc. is one of the largest pharmaceutical companies in the world. Drug treating high cholesterol, hypertension, and heart disease are among the company’s best-sellers. Merck also makes a broad range of drugs to treat other therapeutic areas, including Propencia for male pattern baldness; Singulair for asthma, and Fosamax for osteoporosis. Merck also creates vaccines for children and adults, most recently getting FDA approval for its cervical cancer vaccine Gardasil.
Merck & Co. is part of Business Exchange, suggested by
Ginny Moore.
This topic contains
972 news
and
178 blog
items.
Read updated news, blogs, and resources about Merck & Co.. Find user-submitted articles and reactions on Merck & Co. from
like-minded professionals.
Most Active
The most active stories in this topic based on user activity.
More positive consumer activity and a healthier housing sector outweighed the effects of the drought, caution on the...
Edison Investment Research assesses the value of emerging companies with a model that assumes revenues and earnings are...
Change your attitude and your behavior in ways to develop keen speaking skills to build your personal brand as an...
The drug maker agreed to pay $688 million to settle the two lawsuits that said it harmed investors by delaying the...
Merck's new bone drug appears to work, according to a clinical trial of the osteoporosis treatment that was stopped...
The proposed new drug would combine Merckâs drug Zetia, which lowers âbadâ cholesterol, with the generic version...
Merck beat top-line estimates as it enjoys the benefits of Singulair, its blockbuster drug that raked inn more than $1...
NEW YORK (Reuters) - The head of infectious diseases at Merck & Co said the company's future all-oral treatments...
Rick Perry can withstand charges of executive overreach, but corruption charges could do him in.
InPharm.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news,...
I've heard rumblings from more than one source that Merck may be close to making good on those hefty job cuts that are...
Merck did research that was published last year showing that their 3-question Adherence Estimator (TM) was 86% accurate...
For example, in Australia, Merck allegedly: Had a...
Merck's decision to acquire Schering-Plough (SGP) for $41 billion will improve its bottom line over the next two to...
One option for Johnson & Johnson in response to Merck's bid for Schering-Plough is to make a deal for the latter's...
Startup Topaz Bridge has scored a big hit with its Topaz Bridge S2, an application that lets users work with SAP human...
Merck is a large chemical company based in germany. Merck are working on organic semiconductor materials for displays...
While it has been a see-saw day for the majority of blue chips, Merck & Co., Inc. (NYSE: MRK) has enjoyed today.
...in a January 28, 2010 news article, "Merck Loses Dismissal Bid in Third Fosamax Case", by Bloomberg...
German pharmaceutical and chemical company Merck KGaA said Monday that its first-quarter net profit dropped by 76...
Merck stands to pick up the switch rights to the proton pump inhibitor Zegerid at the head of a strong switch program...
...is important to Merck, its interest in Schering is broad and includes Schering’s strengths in treating...
...of its maker Merck. The Vioxx recall case is analyzed from a perspective including both company profits and public...
Top Sources: Merck & Co.
- Cafepharma Message Boards
- 'The Tan Sheet'
- Reuters
- shearlings got plowed
- In the Pipeline
- BNET Pharma
- BusinessWeek
- Yahoo! Answers: Business & Finance
- Philadelphia Inquirer
- All Journals (past 7 Days)
account